Evidentic
Biosimilar Analytical Reference Medicinal Products
- Home
- What We Do
Products
Aliquots (original buffer)
- Skyrizi®NEW| IL-23 | Risankizumab
- Tremfya®NEW | IL-23 | Guselkumab
- Avastin® | Bevacizumab | VEGF-A
- Bavencio® | Avelumab | PD-L1
- Cyramza® | Ramucirumab | VEGFR 2
- Darzalex® | Daratumumab | CD 38
- Enbrel® | Etanercept | TNF-alpha
- Erbitux® | Cetuximab | EGFR
- Gazyvaro® | Obinutuzumab | CD 20
- Herceptin® | Trastuzumab | HER 2
- Humira® | Adalimumab | TNF-alpha
- Imfinzi® | Durvalumab | PD-L1
- Keytruda® | Pembrolizumab | PD-1
- Mabthera® | Rituximab | CD 20
- Opdivo® | Nivolumab | PD-1
- Perjeta® | Pertuzumab | HER 2
- Prolia® | Denosumab | RANKL
- Remicade® | Infliximab | TNF-alpha
- RoActemra® | Tocilizumab | IL-6 R
- Simponi® | Golimumab | TNF-alpha
- Stelara® | Ustekinumab | IL-12
- Synagis® | Palivizumab | RSVproteinF
- Tecentriq® | Atezolizumab | PD-L1
- Yervoy® | Ipilimumab | CD152 – CTLA4
Dilutions (diluted drug aliquots, 1mg/ml, PBS)
- How To Order
- FAQ
- Downloads
- Contact Us
- About Us
- Therapeutic Antibodies
